| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6063146 | Journal of Allergy and Clinical Immunology | 2015 | 8 Pages |
Abstract
A significant dose-response relationship was demonstrated between chronic SCS use and risk of SCS-related complications in patients with severe asthma. Effective SCS-sparing strategies might reduce the burden associated with SCS-related complications in patients with severe asthma.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Patrick MA, Mei Sheng MPH, ScD, Marie-Hélène MA, Laurence PhD, Urvi PhD, Marie-Noëlle MA, Frank MD, PhD, Steve MSc, Hector MD, ScD, Mark MD, Xiwu PhD, Anand A. PhD, MBA, BPharm,